2022-08-08
Adopted for San Diego "CONNECT" Acceleration Program
CoreTissue BioEngineering has been adopted for The Springboard™ Program in Yokohama, which is supported by Yokohama City and San Diego (CONNECT) in the United States. “The Springboard™ Program in Yokohama” is a program in which the city of Yokohama collaborates with San Diego-based accelerator “CONNECT” to foster and support startup companies in the life science field. Through this program, CoreTissue BioEngineering will accelerate the preparation for the U.S. market of artificial ligaments developed using decellularization technology.
2022-09-26
Our product was introduced on NHK WORLD program "Medical Frontiers"
2022-09-10
Our CEO, Chiaki Waki will present at ”Shaping the Future of Healthtech” on October 6th 10am-11am JST.
2022-08-08
Adopted for San Diego "CONNECT" Acceleration Program
2022-06-29
Yoji Jokura has been appointed as Board Chairman and Chiaki Waki has been appointed as President&CEO.
2022-03-16
CTBE was accepted by Johnson & Johnson Innovation (Boston, U.S.A.) as the first startup company in Japan. It was also interviewed and posted by Nikkei Shimbun.